Gee, who has been buying all of these sub $14, $15 shares? Don't they all know that OSIR's very existence hangs by a thread?
No it is not 100% maintenance required. Scottrade has it at 20%. Now, you are correct that if it is in a cash account, it cannot be borrowed against.
All clinical stage biotechs need "continued financing". It's just the nature of the beast to advance the ball down the field.
And, thank you Janet Yellen for another great buying opportunity. Everyone was selling "risky" biotechs. Well, we have FDA approval. Only risk here is a possible secondary, and I can live with that, if necessary.
And, now a ground offensive begins in Gaza!
The world's on fire ... so sad!!
While one is unfortunate and the other tragic, I'll take a few of these shares off the "seller's" hands!
Appears it was news driven ... With geopolitical tension, I'll hang out in the domestic oil patch, thank you!!
Not HK specific. All O&G stocks fell at the same moment. The robots are in charge today!
Well ... somebody threw a pail of cold water on that little rally effort! Across the sector, not HK specific. Nat gas inventory #s were bearish, is that all they got? lol
The "fools" are saying it's all good!
Depending on one's age, you might recall the "Population Bomb" scare in the 1960's? I think that was "proven science", too. And, then don't forget the prognostications of a coming ICE AGE that never panned out. Follow the $$$$ ... there's gold in them thar myths!!
Check out the biotech ETFs and a lot of smaller biotechs. She made the comment that some of the social media companies and smaller biotechs have "stretched" valuations. And, so it goes ...
I think a LOT has to do with KOG's price. Not much premium there! And, I was in that at .50 "back in the day"!
Check most of our histories ... been here since well below $6. Nobody is sweating your little .80 moves, believe me! Now collect your pennies while you trip over the dollars long term investors will make!
You do realize that by issuing statements or refutations, a company might violate disclosure regulations. I guess you must not have been around when the shorts got reamed on news from $13 to $27? Oh wait ... I'll bet you were one of those brilliant shorts who jumped on at $27? Um hmmmm ....
Thanks oz ... but for now, it appears "advantage ... shorts"!
This, too, shall pass! We've seen this movie before!